Healthcare Quality, Patient Safety & PolicyP4ML Joins Orphan Therapeutics Accelerator to Expand AccessPR NewswireFebruary 26, 2026February 27, 2026 by PR NewswireFebruary 26, 2026February 27, 2026066 P4ML’s Expertise in Genomic Patient Identification, Ties to Middle East Health Initiatives and Irish Biopharmaceutical Roots to be Utilized in Support of OTXL’s Mission & Programs ...
